Skip to main contentAI and Advanced
/
THYROCARE · NSEBSE SENSEX74,479.01+0.22%BSE |
NIFTY 5023,318.6+0.21%NSE |
NIFTY BANK56,177.1+0.22%NSE |
NIFTY IT28,675-1.65%NSE |
NIFTY AUTO27,221.45+0.23%NSE |
NIFTY FMCG45,708.85+0.30%NSE |
NIFTY PHARMA26,642.45+0.24%NSE |
NIFTY 50022,768.8+0.50%NSE |
TH
NSE · Equity shares · Healthcare Facilities2.50 · 0.45%
Thyrocare Technologies THYROCARE
NSE:INR 561.75
BSE:INR 560.5
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for THYROCARE
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 559.25
Day rangeINR 536.1 — INR 560
52-week rangeINR 342.55 — INR 662
Volume1.45 L
Market cap9,643.16
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)829.04
Net Income (INR Cr)163.04
EPS10.31
Research path: Interpret Thyrocare Technologies's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
THYROCAREThyrocare Technologies1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 747.22 | 692.75 | 643.88 |
| Cash Equivalents | 38.32 | 17.68 | 9.3 |
| Other Liabilities Total | 12.11 | 6.94 | 3.06 |
| Common Stock Total | 159.17 | 52.99 | 52.95 |
| Other Current Assets Total | 12.82 | 0.42 | Not available |
| Prepaid Expenses | 6.9 | 8.59 | 2.7 |
| Total Assets | 747.22 | 692.75 | 643.88 |
| Current Portof LT Debt/Capital Leases | 11.51 | 7.76 | 8.94 |
| Cash | 29.84 | 36.8 | 30.59 |
| Total Equity | 585.5 | 546.75 | 526.77 |
| Long Term Investments | 31.8 | 32.06 | 30.84 |
| Retained Earnings(Accumulated Deficit) | 426.33 | 356.47 | 361.04 |
| Total Common Shares Outstanding | 15.92 | 15.9 | 15.89 |
| Property/Plant/Equipment Total-Gross | 3.07 | 439.93 | 396.15 |
| Tangible Book Valueper Share Common Eq | 29.77 | 27.28 | 26.57 |
| Goodwill Net | 108.21 | 108.21 | 104.03 |
| Total Liabilities | 161.72 | 146 | 117.11 |
| Total Debt | 50.69 | 24.68 | 42.34 |
| Short Term Investments | 151.5 | 137.45 | 136.75 |
| Cashand Short Term Investments | 219.66 | 191.93 | 176.64 |
| Total Receivables Net | 82.8 | 82.99 | 46.84 |
| Notes Payable/Short Term Debt | 0 | 0 | 10.69 |
| Accounts Receivable-Trade Net | 73.88 | 73 | 43.47 |
| Property/Plant/Equipment Total-Net | 208.68 | 198.31 | 203.71 |
| Minority Interest | 0.52 | 0.3 | 0.86 |
| Total Current Liabilities | 109.91 | 121.84 | 90.48 |
| Total Inventory | 50.11 | 53.79 | 52.33 |
| Accounts Payable | 65.37 | 76.21 | 40.11 |
| Other Currentliabilities Total | 33.03 | 37.3 | 29.54 |
| Total Long Term Debt | 39.18 | 16.92 | 22.71 |
| Intangibles Net | 3.49 | 4.84 | 0.69 |
| Other Long Term Assets Total | 17.91 | 11.09 | 23.24 |
| Note Receivable-Long Term | 4.84 | 0.52 | 2.86 |
| Total Current Assets | 372.29 | 337.72 | 278.51 |
| Capital Lease Obligations | 39.18 | 16.92 | 11.8 |
| Accumulated Depreciation Total | Not available | -241.62 | -192.45 |
| Accrued Expenses | Not available | 0.57 | 1.2 |
| Long Term Debt | Not available | 0 | 10.91 |
| Other Equity Total | Not available | 54.93 | 34.2 |
| Additional Paid-In Capital | Not available | 78.03 | 74.26 |
| ESOP Debt Guarantee | Not available | 4.33 | 4.32 |
| Deferred Income Tax | Not available | Not available | 0 |
Fundamentals
Valuation and ratios
Valuation
Price to Sale Ratio11.63
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk37.39
Analyst consensus
ConsensusStrong Buy
Consensus score1.40
Analyst opinions5
Strong Sell count0
Sell count0
Hold count0
Buy count2
Strong Buy count3
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter
- 60.92%
- FII
- 5.43%
- MF
- 19.86%
- Other
- 13.79%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Stocks to buy for short term: NMDC, Bank of India among 5 stocks experts recommend for next 1-2 weeksMarket news · 26 May 2026, 10:14 am
Stocks to buy for the short term: Market analysts recommend five promising stocks for the next 1-2 weeks, highlighting bullish trends and strong support zones. Stocks like Bank of India and Thyrocare Technologies show potential for growth, backed by robust technical indicators.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 20 January 2026Market news · 20 Jan 2026, 8:29 am
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Bank of India, Thyrocare Technologies, Can Fin Home, Ashok Leyland, and CEAT
Stocks to buy for short term: Welspun Living, Cummins, Thyrocare among five technical stock picks for this weekMarket news · 1 Dec 2025, 12:19 pm
Stocks to buy for short term: Axis Securities has recommended Welspun Living, Samvardhana Motherson International and Cummins India shares, while Asit C. Mehta Investment Intermediates has recommended Thyrocare Technologies and Sumitomo Chemical India shares to buy for short-term.
Is Thyrocare Technologies share price really down 67% amid record date for 2:1 bonus share issue? ExplainedMarket news · 28 Nov 2025, 2:04 pm
Thyrocare Technologies' shares dropped over 67% on November 28 due to a 2:1 bonus issue, tripling share count while adjusting the price. The stock opened at ₹ 501, reflecting the adjustment, and traded slightly lower at ₹ 489 afterward.
Thyrocare Tech share price pops 17% to a new record high as net profit jumps 82% YoY in Q2Market news · 15 Oct 2025, 11:21 am
Thyrocare Technologies experienced a 16% stock surge to ₹ 1,474 following positive Q2 results and a bonus issue announcement. The company reported 22% revenue growth and an 82% increase in PAT, while expanding its lab presence.
Small-cap stock Thyrocare Tech announces <span class='webrupee'>₹</span>7 dividend, 2:1 bonus issue. Check detailsMarket news · 14 Oct 2025, 5:51 pm
Thyrocare Technologies announced a 2:1 bonus share issue and an interim dividend of ₹ 07. The bonus aims to enhance liquidity and broaden the shareholder base. The company reported a 22% revenue growth, with PAT surging 82% YoY to ₹ 47.90 crore.
Corporate actions
Events
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.7.0000 per share(70%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- bonusBonus issue of equity shares in the ratio of 2:1 of Rs. 10/-.
- annual General MeetingPOM
- dividendRs.7.0000 per share(70%)Interim Dividend
Rusaka Markets Community
Discussion and sentiment for Thyrocare Technologies
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- THYROCARE
- BSE Code
- 539871
Questions
Stock FAQ
What is the symbol and ISIN of Thyrocare Technologies?
Thyrocare Technologies has the symbol THYROCARE and ISIN - INE594H01019.
What is the current price of Thyrocare Technologies?
Thyrocare Technologies is currently trading at INR 561.75.
What are the year high and year low of Thyrocare Technologies?
Thyrocare Technologies has a year high of INR 662.00 and a year low of INR 342.55.
What is the market capitalization of Thyrocare Technologies?
Thyrocare Technologies has a market capitalization of INR 9,643.16 crore.
What is the P/E ratio of Thyrocare Technologies?
Thyrocare Technologies has a P/E ratio of NA.
What is the dividend yield of Thyrocare Technologies?
Thyrocare Technologies has a dividend yield of NA.
How is the financial performance of Thyrocare Technologies based on revenue, net income, and EPS?
Thyrocare Technologies has revenue of INR 829.04 crore, net income of INR 163.04 crore, and EPS of NA.
What is the book value of Thyrocare Technologies?
Thyrocare Technologies has a book value of NA.
What is the debt-to-equity ratio of Thyrocare Technologies?
Thyrocare Technologies has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Thyrocare Technologies?
Thyrocare Technologies has a price-to-book ratio of NA and a price-to-sales ratio of 11.63.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.